# FDA Inspection 833285 - Stanford Clinical Laboratory at Hillview - May 22, 2013

Source: https://www.keypedia.com/records/fda_inspections/stanford-clinical-laboratory-at-hillview/7c8e6fea-7b29-44d9-b74e-c36d057c4ce4
Source feed: FDA_Inspections

> FDA Inspection 833285 for Stanford Clinical Laboratory at Hillview on May 22, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 833285
- Company Name: Stanford Clinical Laboratory at Hillview
- Inspection Date: 2013-05-22
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 984041 - 2016-08-22](https://www.keypedia.com/records/fda_inspections/stanford-clinical-laboratory-at-hillview/ec133685-b68e-4720-97f3-a37089a0cb77)
- [FDA Inspection 713984 - 2011-03-11](https://www.keypedia.com/records/fda_inspections/stanford-clinical-laboratory-at-hillview/3bb0f340-4773-49da-8253-c5134c7c78fb)
- [FDA Inspection 680697 - 2010-09-16](https://www.keypedia.com/records/fda_inspections/stanford-clinical-laboratory-at-hillview/970b106c-c1c8-48f5-bcd5-6292765c1070)

Company: https://www.keypedia.com/companies/stanford-clinical-laboratory-at-hillview/24075059-19e0-4d75-b60e-b49bfa78b058

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d